Advertisement
Loading...

BioMark Diagnostics Inc.

BMKDF•PNK
Healthcare
Medical - Diagnostics & Research
$0.50
$0.06(14.64%)
U.S. Market opens in 12h 38m
Advertisement

BioMark Diagnostics Inc. (BMKDF) Stock Overview

Explore BioMark Diagnostics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap53M
P/E Ratio-43.14
EPS (TTM)$-0.01
ROE-1.53%
Fundamental Analysis

AI Price Forecasts

1 Month$0.43
3 Months$0.48
1 Year Target$0.41

BMKDF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioMark Diagnostics Inc. (BMKDF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 89.86, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -43.14 and a market capitalization of 53M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
14.64%
5-Day Change
14.74%
1-Month Change
21.57%
3-Month Change
33.65%
6-Month Change
108.69%
Year-to-Date (YTD) Change
47.10%
1-Year Change
132.17%
3-Year Change
134.60%
5-Year Change
56.35%
All-Time (Max) Change
46.20%

Contact Information

https://www.biomarkdiagnostics.com
604 370 0779
3851 Shell Road, Richmond, BC, V6X 2W2

Company Facts

9 Employees
IPO DateMar 23, 2015
CountryCA
Actively Trading

Frequently Asked Questions